NLSP NLS Pharmaceutics Ltd., NLSPW NLS Pharmaceutics Ltd. - 6-K - (2025-11-04)

NewCelX Ltd. Form 6-K Summary (Nov 2025)

NewCelX Ltd. (Swiss issuer) filed a Form 6-K reporting a material event:

Investors should immediately review the content of Exhibit 99.1 for strategic updates, performance commentary

...

Join thousands of investors who never miss important market updates

Join